No Data
Notable Healthcare Headlines for the Week: Merck, Roche and Bausch Health in Focus
Benzinga Bulls And Bears: Netflix, Novavax, Intel — And The Market Begins To Bounce Back
The Trump administration plans to impose tariffs on imported Pharmaceuticals, and the U.S. Pharmaceutical Industry warns that it may increase drug costs.
A report commissioned by a trade organization in the USA Pharmaceutical Industry indicates that if the USA imposes a 25% tariff on imported Pharmaceuticals, it could increase the annual Pharmaceutical costs in the USA by nearly 51 billion dollars and raise drug prices by up to 12.9%.
News Highlights: Top Company News of the Day - Friday at 5 PM ET
Novavax Inc. Stock Slides 5.7%, Underperforms Competitors
Market Chatter: Novavax Asked by FDA to Run Additional Trial on COVID-19 Vaccine
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
JC88 OP : Adding a disclaimer, the purpose of sharing is to be transparent (so you know i am not bullsheting and is still holding).. Please do not take this as any financial advice. Investment comes with risk and is only for those with balls made of steel.
Only play with what you can afford to lose.
Flying Cow : So, when most likely to go back to 100?
JC88 OP Flying Cow : i wont be selling at 100.
Flying Cow JC88 OP : Don't really care when you sell. As per your experience on this, when can go up to 100?